Skip to main content
Log in

Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: the Modena Study Group proposal

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Hereditary factors play a fundamental role in the pathogenesis of breast cancer (BC). Approximately 15–20% of all BCs have been reported to show familial clustering. In spite of the recent demonstration and chromosomal localization of BC predisposing genes, clinical clues and careful inspection of pedigree still remain major instruments in HBC diagnosis. The aim of the present study was to develop minimum operational criteria for the selection of family groups at high risk of developing BC. Following a stepwise procedure, families were stratified into four clusters with increasing probability of genetic involvement. So far, 317 BC‐prone families have been identified and distributed in the four groups, and 151 high risk women underwent our clinical and mammographic surveillance program. Among these, after a mean follow‐up of 24 months, six BCs and one OC were diagnosed (one BC and one OC occurred in the same woman) and one ‘interval’ BC was observed. Since the prevalence rate so far detected is dramatically higher than that seen at the first round of Italian population‐screening programs, our preliminary data support the usefulness of the proposed procedure in selecting high risk individuals.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Israeli D, Tartter PI, Brower ST, Mizrachy B, Bratton J: The significance of family history for patients with carcinoma of the breast. J Am Coll Surg 179: 29-32, 1994

    Google Scholar 

  2. Lynch HT, Lynch J, Conway T, Watson P, Feunteun J, Lenoir G, Narod 5, Fitgibbons R, Jr.: Hereditary breast cancer and family cancer syndromes. World J Surg 18: 21-31, 1994

    Google Scholar 

  3. Newman B, Austin MA, Lee M, King MC: Inheritance of human breast cancer: Evidence for autosomal dominant transmission in high risk families. Proc Natl Acad Sci USA 85: 3044-3048, 1988

    Google Scholar 

  4. Li FP, Garber JE, Friend FH, Strong LC, Patenaude AF, Juengst ET, Reilly PR, Correa P, Fraumeni JF, Jr.: Recommendations of predictive testing for germ-line p53 mutations among cancer-prone individuals. J Natl Cancer Inst 84: 1156-1160, 1992

    Google Scholar 

  5. Birch JM: The Li-Fraumeni cancer family syndrome. J Pathol 161: 1-2, 1990

    Google Scholar 

  6. Morrell D, Cromartie E, Swift M: Mortality and cancer incidence in 263 patients with AT. JNCI 77: 89-92, 1986

    Google Scholar 

  7. Lynch HT, Guirgis HA, Albert 5, Brennan M, Lynch J, Kraft C, Pocekay D, Vaughns C, Kaplan A: Familial association of carcinoma of the breast and ovary. Surg Gynecol Obstet 138: 717-724, 1974

    Google Scholar 

  8. Lynch HT, Krush AJ, Guirgis H: Genetic factors in families with combined gastrointestinal and breast cancer. Am J Gastroenterol 59: 31-40, 1973

    Google Scholar 

  9. Padberg GW, Schot JD, Vielvoye GJ, Bots GT, de Beer FC: Lhermitte-Duclos disease and Cowden disease: A single phakomatosis. Ann Neurol 29: 517-523, 1991

    Google Scholar 

  10. Lynch HT, Watson P, Conway TA, Lynch JF: Natural history and age at onset of hereditary breast cancer. Cancer 69: 1404-1407, 1992

    Google Scholar 

  11. Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC: Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250: 1684-1689, 1990

    Google Scholar 

  12. Wooster R, Neuhausen S, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D, Fields P, Marshall G, Narod S, Lenoir GM, Lynch H, Feunteun J, Devilee P, Cornelisse CJ, Menko FH, Daly PA, Ormiston W, McManus R, Pye C, Lewis CM, Cannon-Albright LA, Peto J, Ponder BA, Skolnick MH, Easton DF, Goldgar DE, Stratton MR: Localization of a breast susceptibility gene, BRCA2, to chromosome 13q 12–13. Science 265: 2088, 1994

    Google Scholar 

  13. Malkin D, Li FP, Strong LC, Fraumeni JF, Jr., Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science 250: 1233-1238, 1990

    Google Scholar 

  14. Savitsky K, Sfez 5, Tagle DA, Ziv Y, Sartiel A, Collins FS, Shiloh Y, Rotman G: The complete sequence of the coding region of ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet 4: 2025-2032, 1995

    Google Scholar 

  15. Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero, Bonney G, Gold K, Trock B, Main D, Lynch J, Fulmore C, Snyder C, Lemon S, Conway T, Tonin P, Lenoir G, Lynch H: BRCA1 testing in families with hereditary breastovarian cancer: A prospective study of patient decision making and outcomes. JAMA 275: 1885-1892, 1996

    Google Scholar 

  16. Lynch HT, Watson P, Conway T, Fitzimmons ML, Lynch J: Breast cancer family history as a risk factor for early onset breast cancer. Breast Cancer Res Treat 11: 263-267, 1988

    Google Scholar 

  17. Burke W, Daly M, Garber J, Botkin J, Kahn MJE, Lynch P, McTieman A, Offit K, Perlman J, Petersen G, Thomson E, Varricchio C, for the Cancer Genetics Studies Consortium: Recommendations for follow-up care of individuals with an inherited predisposition to cancer. JAMA 277: 997-1008, 1997

    Google Scholar 

  18. Lynch HT, Watson P, Conway TA, Lynch JF: Clinical/genetic features in hereditary breast cancer. Breast Cancer Res Treat 15: 63-71, 1990

    Google Scholar 

  19. Vasen HFA, Mecklin JP, Watson P, Utsunomiya J, Bertario L, Lynch P, Svendsen LB, Cristofaro G, Muller H, Khan PM: Surveillance in HNPCC: An international cooperative study of 165 families. Dis Colon Rectum 36: 1-4, 1993

    Google Scholar 

  20. Zelada-Hedman M, Wasteson Arver B, Claro A, Chen J, Werelius B, Kok H, Sandelin K, Hakansson S, Andersen TI, Borg A, Borresen Dale AL, Lindblom A: A screening for BRCA1 mutations in breast and breast-ovarian cancer families from the Stockholm region. Cancer Res 57: 2474-2477, 1997

    Google Scholar 

  21. Vasen HFA, Mecklin JP, Khan PM, Lynch TH: The International Collaborative Study Group on Hereditary Nonpolyposis Colorectal Cancer. Dis Colon Rectum 34: 424-425, 1991

    Google Scholar 

  22. Claus EB: The calculation of breast cancer risk for women with a first degree family history of ovarian cancer. Cancer 73: 643, 1993

    Google Scholar 

  23. Sattin RW, Rubin GL, Webster LA, Huezo CM, Wingo PA, Ory HW, Layde PM: Family history and risk of breast cancer. JAMA 253: 1908-1913, 1985

    Google Scholar 

  24. Walker RA, Lees E, Webb MB, Dearing SJ: Breast carcinomas occurring in young women (35 years) are different. Br J Cancer 74: 1796-1800, 1996

    Google Scholar 

  25. Otten JD, van Dick JA, Peer PG, Straatman H, Verbeek AL, Mravunac M, Hendrikis JH, Holland R: Long term breast cancer screening in Nijmegen, The Netherlands: The nine rounds from 1975–92. J Epidemiol Commun Health 50: 353-358, 1996

    Google Scholar 

  26. Evans WP III, Starr AL, Bennos S: Comparison of the relative incidence of impalpable invasive breast carcinoma and ductal carcinoma in situ in cancers detected in patients older and younger than 50 years of age. Radiology 204: 489-491, 1997

    Google Scholar 

  27. John V, Ewen K, Kurz E, Teske HJ: Value of different systems of mammography records with regard to their exposure to radiation and their information content. Strahlentherapie 154: 101-106, 1978

    Google Scholar 

  28. Mettler FA, Upton AC, Kelsey CA, Ashby RN, Rosenberg RD, Linver MN: Benefits versus risks from mammography: A critical reassessment. Cancer 77: 903-909, 1996

    Google Scholar 

  29. Vasen HFA, Offerhaus GJA, den Hartog Jager FC, Menko FH, Nagengast FM, Griffioen G, van Hogezand RB, Heintz AP: The tumour spectrum in hereditary non-polyposis colorectal cancer: A study of 24 kindreds in The Netherlands. Int J Cancer 46: 31-34, 1990

    Google Scholar 

  30. Filippini L, Braga M, Perna E, Bianchi AM, Bettoni C, Lucini L, Pezzola D, Pinelli D, Tonini G, Callea F: Results of a mammographic and clinical screening in a health district (USSL) of Brescia, Italy. Tumori 82: 430-436, 1996

    Google Scholar 

  31. Paci E, Ciatto S, Buiatti E, Cecchini S, Palli D, Rosselli del Turco M: Early indicators of efficacy of breast cancer screening programmes: Results of the Florence District Programme. Int J Cancer 46: 198-202, 1990

    Google Scholar 

  32. Elston CW: The assessment of histological differentiation in breast cancer. Aust N Z J Surg 54: 11-15, 1984

    Google Scholar 

  33. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer: I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology 19: 403-410, 1991

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Federico, M., Maiorana, A., Mangone, L. et al. Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: the Modena Study Group proposal. Breast Cancer Res Treat 55, 213–221 (1999). https://doi.org/10.1023/A:1006192230332

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006192230332

Navigation